TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33208155

Group type: EXPERIMENTAL
Intervention: Adaptive designs
Number of subjects: 0
Study: 35084726

Group type: EXPERIMENTAL
Intervention: Nebulized heliox (helium/oxygen‐70: 30) plus albuterol (10 mL/min for 20 minutes, three times)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Standard treatment (albuterol in combination with oxygen)
Number of subjects: 109
Study: 33370083

Group type: EXPERIMENTAL
Intervention: Rapid Cycle Deliberate Practice (RCDP) booster training
Number of subjects: 30

Group type: COMPARATOR
Intervention: Usual practice (plus/delta)
Number of subjects: 30
Study: 34091155

Group type: EXPERIMENTAL
Intervention: Stress task
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control task
Number of subjects: 30
Study: 32250418

Group type: EXPERIMENTAL
Intervention: True filtration device
Number of subjects: 43

Group type: COMPARATOR
Intervention: Sham filtration device
Number of subjects: 43
Study: 615776683

Group type: EXPERIMENTAL
Intervention: Pulsed magnetic stimulation (PMS), 2 sessions per week for 2 months (16 sessions)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Pulsed magnetic stimulation (PMS)
Number of subjects: 120
Study: 35450475

Group type: COMPARATOR
Intervention: Endovascular thrombectomy alone
Number of subjects: 1633

Group type: EXPERIMENTAL
Intervention: Endovascular thrombectomy with intravenous thrombolysis
Number of subjects: 1633
Study: 34303029

Group type: EXPERIMENTAL
Intervention: SRP+aPDT (scaling and root planing followed by 3 consecutive applications of antimicrobial photodynamic therapy)
Number of subjects: 34

Group type: COMPARATOR
Intervention: SRP (scaling and root planing)
Number of subjects: 34
Study: 35403286

Group type: EXPERIMENTAL
Intervention: Probiotic and Peanut Oral Immunotherapy (PPOIT)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study: 35162622

Group type: EXPERIMENTAL
Intervention: Cool water immersion (18 °C)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control trial (thermoneutral environment)
Number of subjects: 10
Study: 33601335

Group type: EXPERIMENTAL
Intervention: Low-Frequency (LF) resistance exercise training (10 × 10 repetitions at 70% one-repetition maximum, once per week)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: High-Frequency (HF) resistance exercise training (2 × 10 repetitions at ∼70% one-repetition maximum, five times per week)
Number of subjects: 9

Group type: COMPARATOR
Intervention: BASAL (7-day period of habitual physical activity)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: First 2 days of exercise training
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Last 5 days of exercise training
Number of subjects: 9
Study: 32546065

Group type: EXPERIMENTAL
Intervention: Exercise-based prehabilitation (EBPrehab) program, two-week duration, including supervised aerobic exercise.
Number of subjects: 230

Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 230
Study: 35198631

Group type: EXPERIMENTAL
Intervention: Manipulation with arthrographic distention
Number of subjects: 180

Group type: COMPARATOR
Intervention: Arthrographic distention alone (Control)
Number of subjects: 180
Study: 32999089

Group type: EXPERIMENTAL
Intervention: Radial access with a compression device
Number of subjects: 250

Group type: COMPARATOR
Intervention: Femoral access with a hemostatic vascular closure device
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Radial access
Number of subjects: 250

Group type: COMPARATOR
Intervention: Meta-analysis
Number of subjects: 250
Study: 36321798

Group type: EXPERIMENTAL
Intervention: Capillary sodium measurement
Number of subjects: 100

Group type: COMPARATOR
Intervention: Venous sodium measurement
Number of subjects: 100
Study: 33392744

Group type: EXPERIMENTAL
Intervention: 20% maximal voluntary contraction (MVC) with wide pulse width (1 ms) NMES
Number of subjects: 20

Group type: COMPARATOR
Intervention: 30% maximal voluntary contraction (MVC) NMES
Number of subjects: 20

Group type: COMPARATOR
Intervention: 10% maximal voluntary contraction (MVC) NMES
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 5 x 2-s NMES bouts
Number of subjects: 20
Study: 32967576

Group type: EXPERIMENTAL
Intervention: Stroke clock intervention
Number of subjects: 107

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 107
Study: 35368052

Group type: EXPERIMENTAL
Intervention: SLN360 30 mg
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: SLN360 100 mg
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: SLN360 300 mg
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: SLN360 600 mg
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 34898916

Group type: EXPERIMENTAL
Intervention: Nano‐crystalline silver dressing (Acticoat ™)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Noneugenol dressing
Number of subjects: 42
Study: 32020296

Group type: COMPARATOR
Intervention: Nester coils
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: IDC coils
Number of subjects: 25
Study: 33758008

Group type: EXPERIMENTAL
Intervention: P2Y12 inhibitor monotherapy after 3-month DAPT
Number of subjects: 2993

Group type: COMPARATOR
Intervention: 12-month DAPT
Number of subjects: 2993
Study: 32859432

Group type: EXPERIMENTAL
Intervention: mTNrM staging system
Number of subjects: 18139

Group type: EXPERIMENTAL
Intervention: mTNrM staging subgroups
Number of subjects: 18139

Group type: COMPARATOR
Intervention: TNM and TNrM staging systems
Number of subjects: 18139
Study: 35717303

Group type: EXPERIMENTAL
Intervention: Pregaming Awareness in College Environments (PACE) intervention
Number of subjects: 500

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 500
Study: 36251618

Group type: EXPERIMENTAL
Intervention: Levoketoconazole (150-600 mg BID)
Number of subjects: 60
Study: 33148737

Group type: EXPERIMENTAL
Intervention: Exergames training (40-minute sessions, 2 times per week for 10 weeks)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Kinesiotherapy protocol (control group)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Exergames training
Number of subjects: 42
Study: 35797395

Group type: EXPERIMENTAL
Intervention: DES with cilostazol
Number of subjects: 85

Group type: COMPARATOR
Intervention: DES
Number of subjects: 85

Group type: COMPARATOR
Intervention: BNS with cilostazol
Number of subjects: 85

Group type: COMPARATOR
Intervention: BNS
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: DES with cilostazol (small vessels)
Number of subjects: 85

Group type: COMPARATOR
Intervention: DES (small vessels)
Number of subjects: 85
Study: 33870762

Group type: EXPERIMENTAL
Intervention: Exercise Training (ET)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Exercise Training plus Kinesio Taping (ET + KT)
Number of subjects: 22
Study: 32124456

Group type: EXPERIMENTAL
Intervention: Skin marker intervention using single-use sterile Gentian violet skin marker pens.
Number of subjects: 13991

Group type: COMPARATOR
Intervention: Control group (no skin marker intervention).
Number of subjects: 13991

Group type: EXPERIMENTAL
Intervention: Both groups (skin marker and control).
Number of subjects: 13991

Group type: EXPERIMENTAL
Intervention: Skin marker intervention.
Number of subjects: 13991
Study: 33926788

Group type: EXPERIMENTAL
Intervention: High-flow three-way stopcock (HTS)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Normal-flow three-way stopcock (NTS)
Number of subjects: 20
Study: 34040074

Group type: EXPERIMENTAL
Intervention: V1/V2 ratio
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: V2/V3 ratio
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: V3/V4 ratio
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: V4/V5 ratio
Number of subjects: 100
Study: 36643366

Group type: EXPERIMENTAL
Intervention: Bupivacaine-soaked tachosil and restoration of intraabdominal surface tension
Number of subjects: 816

Group type: COMPARATOR
Intervention: Control group (no bupivacaine-soaked tachosil)
Number of subjects: 816
Study: 33609624

Group type: EXPERIMENTAL
Intervention: Benralizumab Q4W
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Benralizumab Q8W
Number of subjects: 86

Group type: COMPARATOR
Intervention: Placebo/Q8W
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Q8W/Q8W
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Benralizumab Q4W and Q8W
Number of subjects: 86
Study: 32788142

Group type: EXPERIMENTAL
Intervention: PediAppRREST app
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (no app)
Number of subjects: 48
Study: 32488909

Group type: EXPERIMENTAL
Intervention: Bevacizumab in combination with neoadjuvant chemotherapy (FEC100 and taxanes)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Bevacizumab
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Paclitaxel
Number of subjects: 132
Study: 36419615

Group type: EXPERIMENTAL
Intervention: 4D dietary supplement containing 150 mg of caffeine
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo (non-caffeinated)
Number of subjects: 17
Study: 32128957

Group type: EXPERIMENTAL
Intervention: Efpeglenatide 8 mg once monthly
Number of subjects: 209

Group type: EXPERIMENTAL
Intervention: Efpeglenatide 12 mg once monthly
Number of subjects: 209

Group type: EXPERIMENTAL
Intervention: Efpeglenatide 16 mg once monthly
Number of subjects: 209

Group type: EXPERIMENTAL
Intervention: Efpeglenatide overall
Number of subjects: 209

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 209
Study: 36201889

Group type: EXPERIMENTAL
Intervention: Sleeping Sound intervention
Number of subjects: 123
Study: 34224858

Group type: EXPERIMENTAL
Intervention: Mastiha
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32886918

Group type: EXPERIMENTAL
Intervention: Ventricular lavage/irrigation
Number of subjects: 33

Group type: COMPARATOR
Intervention: Conventional therapy (external ventricular drain with antibiotics)
Number of subjects: 33
Study: 32915670

Group type: EXPERIMENTAL
Intervention: Writing for Recovery (WfR) intervention, six sessions
Number of subjects: 54

Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 54
Study: 35352014

Group type: EXPERIMENTAL
Intervention: Beetroot juice (providing 6.4 mmol NO3)
Number of subjects: 25

Group type: COMPARATOR
Intervention: NO3-depleted beetroot juice (control)
Number of subjects: 25
Study: 32991606

Group type: EXPERIMENTAL
Intervention: Pelubiprofen CR 90 mg
Number of subjects: 191

Group type: COMPARATOR
Intervention: Aceclofenac 200 mg
Number of subjects: 191
Study: 35743685

Group type: EXPERIMENTAL
Intervention: Chitosan conduit
Number of subjects: 47

Group type: COMPARATOR
Intervention: Autologous nerve graft
Number of subjects: 47
Study: 32115753

Group type: EXPERIMENTAL
Intervention: RAI oral/dental items assessment
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Communication processes for RAI assessments
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Integration of care aides in assessment processes
Number of subjects: 44
Study: 33589759

Group type: EXPERIMENTAL
Intervention: Validated home blood pressure monitors (HBPMs)
Number of subjects: 21104

Group type: EXPERIMENTAL
Intervention: Non-validated home blood pressure monitors (HBPMs)
Number of subjects: 21104

Group type: EXPERIMENTAL
Intervention: Upper arm HBPMs
Number of subjects: 21104

Group type: EXPERIMENTAL
Intervention: Wrist HBPMs
Number of subjects: 21104

Group type: EXPERIMENTAL
Intervention: Validated HBPMs
Number of subjects: 21104
Study: 34438356

Group type: EXPERIMENTAL
Intervention: Cognitive and behavioural mediators
Number of subjects: 640

Group type: COMPARATOR
Intervention: Physical functioning and fatigue outcomes
Number of subjects: 640
Study: 35276789

Group type: EXPERIMENTAL
Intervention: Low salt intervention
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: High-nitrate vegetable intervention
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Combined high-nitrate vegetable and low salt intervention
Number of subjects: 74

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 74
Study: 35961692

Group type: COMPARATOR
Intervention: Aspirin and clopidogrel (AC)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Aspirin and ticagrelor (AT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Aspirin and prasugrel (AP)
Number of subjects: 0
Study: 32058247

Group type: EXPERIMENTAL
Intervention: Ambulatory assessment of attentional bias (AB) to smoking cues
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Ambulatory assessment of attentional bias (AB) to alcohol cues
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Comparison of smoking AB and alcohol AB
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Association of AB with craving
Number of subjects: 21
Study: 34296383

Group type: EXPERIMENTAL
Intervention: Mailed SCP
Number of subjects: 378

Group type: EXPERIMENTAL
Intervention: SCP delivered during an in‐person survivorship visit
Number of subjects: 378

Group type: EXPERIMENTAL
Intervention: SCP delivered during an in‐person survivorship visit plus 6‐month follow‐up
Number of subjects: 378

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 378
Study: 34479632

Group type: EXPERIMENTAL
Intervention: Emotion-focused mindfulness therapy (EFMT) delivered via telehealth (Zoom)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Wait list control (no treatment)
Number of subjects: 48
Study: 35711820

Group type: EXPERIMENTAL
Intervention: 50 mg intramuscular nandrolone
Number of subjects: 23

Group type: COMPARATOR
Intervention: Normal saline placebo
Number of subjects: 23
Study: 32160888

Group type: EXPERIMENTAL
Intervention: Angioembolization after PCNL
Number of subjects: 53

Group type: COMPARATOR
Intervention: No angioembolization after PCNL
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Puncture correctness
Number of subjects: 53
Study: 36254494

Group type: EXPERIMENTAL
Intervention: Targeting and Re‐aligning Agriculture to Improve Nutrition (TRAIN) programme
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nutrition counselling, agriculture extension, supervision, training, monitoring and evaluation, community events
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Personnel, travel, supplies
Number of subjects: 0
Study: 32835958

Group type: EXPERIMENTAL
Intervention: Counterconditioning (imagery counterconditioning protocol)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No Counterconditioning (standard ExRP)
Number of subjects: 0
Study: 34613339

Group type: EXPERIMENTAL
Intervention: Systemic treatment (fluoropyrimidine-based chemotherapy with bevacizumab)
Number of subjects: 196

Group type: COMPARATOR
Intervention: Primary tumor resection (PTR) followed by systemic treatment (fluoropyrimidine-based chemotherapy with bevacizumab)
Number of subjects: 196
Study: 36188617

Group type: EXPERIMENTAL
Intervention: Tailin formulation (TLF) + Continuous low-dose antibiotic therapy (CLAT)
Number of subjects: 195

Group type: COMPARATOR
Intervention: Continuous low-dose antibiotic therapy (CLAT)
Number of subjects: 195
Study: 32936838

Group type: EXPERIMENTAL
Intervention: Polyclonal sera from genotype B5- or C4-infected patients
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Human monoclonal antibodies (MAbs) derived from genotype B5 virus-infected individuals
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Neutralizing antibodies targeting VP1 S241, VP3 E81, and VP2 D84 on genotype C1 viral capsid
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Neutralizing antibodies in hSCARB2-transgenic mice model
Number of subjects: 23
Study: 35242191

Group type: EXPERIMENTAL
Intervention: L‐PRF over ATBG around immediately inserted implants (test group)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (without L‐PRF)
Number of subjects: 26
Study: 33568038

Group type: EXPERIMENTAL
Intervention: Kinesitherapy combined with daily administration of Fortigel®, Vitamin C, sodium hyaluronate, manganese and copper (Group B)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Kinesitherapy alone (Group A)
Number of subjects: 60
Study: 34101206

Group type: EXPERIMENTAL
Intervention: Low fluence Q switched ND:YAG 1064-nm laser (6 sessions)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Topical silymarin cream 1.4% (3-month treatment)
Number of subjects: 50
Study: 32778175

Group type: EXPERIMENTAL
Intervention: D-ribose supplementation (15g in 200ml solution)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: D-ribose supplementation
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo (sorbitol and β-cyclodextrin)
Number of subjects: 21
Study: 34254731

Group type: EXPERIMENTAL
Intervention: Tai Chi intervention (1-hour class twice weekly for 16 weeks)
Number of subjects: 160
Study: 36435003

Group type: EXPERIMENTAL
Intervention: Midwife-led weight management program
Number of subjects: 426

Group type: COMPARATOR
Intervention: Conventional obstetrician-led antenatal care
Number of subjects: 426
Study: 33432459

Group type: EXPERIMENTAL
Intervention: Salacia chinensis (SC; 500 mg)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 32546796

Group type: EXPERIMENTAL
Intervention: Supervised hospital-based moderate to high intensity group exercise intervention
Number of subjects: 153

Group type: COMPARATOR
Intervention: Instructed home-based individual pedometer intervention
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Positive cardiorespiratory fitness responders
Number of subjects: 153
Study: 35700052

Group type: EXPERIMENTAL
Intervention: Cash + Care (C+C)
Number of subjects: 5116

Group type: COMPARATOR
Intervention: Care
Number of subjects: 5116
Study: 33632647

Group type: EXPERIMENTAL
Intervention: Kids’ meals are the right size for children
Number of subjects: 2373

Group type: EXPERIMENTAL
Intervention: Doctors recommend a 600 kcal per meal limit for kids
Number of subjects: 2373

Group type: EXPERIMENTAL
Intervention: 600 kcal per meal is a generally recommended limit for kids
Number of subjects: 2373

Group type: COMPARATOR
Intervention: Nonfood control
Number of subjects: 2373
Study: 33040778

Group type: EXPERIMENTAL
Intervention: Dengzhanshengmai capsules combined with butylphthalide softgels
Number of subjects: 123

Group type: COMPARATOR
Intervention: Control group A (butylphthalide soft capsules)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Control group B (Dengzhanshengmai capsules)
Number of subjects: 123
Study: 35954543

Group type: EXPERIMENTAL
Intervention: Sedentary workplace intervention
Number of subjects: 24
Study: 34709582

Group type: EXPERIMENTAL
Intervention: Dapagliflozin 5 mg
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Sitagliptin 50 mg
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Metformin 1000 mg
Number of subjects: 32
Study: 33852508

Group type: EXPERIMENTAL
Intervention: Nursing care with gliclazide
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Nursing care with pioglitazone hydrochloride
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Nursing care with sitagliptin
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Nursing care with exenatide
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Nursing care with liraglutide
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group with gliclazide
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group with pioglitazone hydrochloride
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group with sitagliptin
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group with exenatide
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group with liraglutide
Number of subjects: 90
Study: 36376930

Group type: EXPERIMENTAL
Intervention: Glucocorticoid treatment
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: HITAS score
Number of subjects: 280
Study: 36074960

Group type: EXPERIMENTAL
Intervention: Modified Milch technique
Number of subjects: 126

Group type: COMPARATOR
Intervention: Hippocratic method (Control)
Number of subjects: 126
Study: 32746033

Group type: EXPERIMENTAL
Intervention: LASSO regression with extended feature-set including quadratic terms (LASSO_Q)
Number of subjects: 218

Group type: COMPARATOR
Intervention: Standard formula (SF)
Number of subjects: 218

Group type: COMPARATOR
Intervention: Literature methods (three ΔG-accounting variants)
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: LASSO_Q
Number of subjects: 218
Study: 32443179

Group type: EXPERIMENTAL
Intervention: Poll measuring respondent approval for Medicare For All (MFA) with the name and description
Number of subjects: 5051

Group type: EXPERIMENTAL
Intervention: Poll measuring approval for Medicaid Buy-In (MBI) with the name and description
Number of subjects: 5051

Group type: COMPARATOR
Intervention: Poll measuring approval for Medicare For All (MFA) with only a description
Number of subjects: 5051

Group type: COMPARATOR
Intervention: Poll measuring approval for Medicaid Buy-In (MBI) with only a description
Number of subjects: 5051
Study: 35084377

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study: 32005294

Group type: EXPERIMENTAL
Intervention: Integrated nutrition, health, water sanitation and hygiene, psychosocial care and support intervention package delivered during the pre and peri-conception period and/or during pregnancy and early childhood
Number of subjects: 13500

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 13500
Study: 35900386

Group type: EXPERIMENTAL
Intervention: Topical tranexamic acid (TXA) 500 mg/5 ml
Number of subjects: 26

Group type: COMPARATOR
Intervention: Moffett’s solution (control)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 26
Study: 33509935

Group type: EXPERIMENTAL
Intervention: 5 exercise sessions on 5 consecutive days (5S)
Number of subjects: 26

Group type: COMPARATOR
Intervention: 2 exercise sessions on 2 days (2S)
Number of subjects: 26
Study: 32273589

Group type: EXPERIMENTAL
Intervention: Inoculation with Azospirillum brasilense and silicon (Si)
Number of subjects: 4

Group type: COMPARATOR
Intervention: Inoculation with Azospirillum brasilense
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Silicon (Si) use
Number of subjects: 4
Study: 34269243

Group type: EXPERIMENTAL
Intervention: Verbal + pictorial postoperative care instructions (Group B)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Verbal postoperative care instructions (Group A)
Number of subjects: 39
Study: 32268161

Group type: EXPERIMENTAL
Intervention: Mobile app follow-up
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional follow-up
Number of subjects: 60
Study: 32270544

Group type: EXPERIMENTAL
Intervention: 75 cl bottles
Number of subjects: 186

Group type: COMPARATOR
Intervention: 50 cl bottles
Number of subjects: 186